Posts Tagged ‘European Federation of Pharmaceutical Industries and Associations’

Part 2: The European Repackaging Debate – Last week we witnessed the confusing practice of repackaging of prescription medicines within the European Union (EU) through the eyes of a fictitious Dutch patient picking up his blood pressure tablets at a city retail pharmacy. The patient’s experience is shared by millions of Europeans living in Germany, Great Britain, and Holland among other countries. Under current EU rules, medicines can be re-boxed or re-labeled after they leave the site of production, and tablets can be removed from their blisters and reconditioned. Counterfeiters can exploit this fact in order to sneak their fake goods past regulators. One of the prime sources of counterfeit medicines, which can enter the drug supply at the point of repackaging, is the Internet.